Free Trial

Mind Medicine (MindMed) (MNMD) Stock Price, News & Analysis

Mind Medicine (MindMed) logo
$7.20 +0.12 (+1.69%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$7.15 -0.05 (-0.69%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Mind Medicine (MindMed) Stock (NASDAQ:MNMD)

Key Stats

Today's Range
$7.00
$7.25
50-Day Range
$6.16
$7.89
52-Week Range
$4.70
$10.44
Volume
583,979 shs
Average Volume
1.33 million shs
Market Capitalization
$543.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.50
Consensus Rating
Buy

Company Overview

Mind Medicine (MindMed) Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

MNMD MarketRank™: 

Mind Medicine (MindMed) scored higher than 61% of companies evaluated by MarketBeat, and ranked 389th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Mind Medicine (MindMed) has received a consensus rating of Buy. The company's average rating score is 3.27, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Mind Medicine (MindMed) has only been the subject of 2 research reports in the past 90 days.

  • Read more about Mind Medicine (MindMed)'s stock forecast and price target.
  • Earnings Growth

    Earnings for Mind Medicine (MindMed) are expected to grow in the coming year, from ($1.35) to ($0.74) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mind Medicine (MindMed) is -5.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mind Medicine (MindMed) is -5.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Mind Medicine (MindMed) has a P/B Ratio of 2.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Mind Medicine (MindMed)'s valuation and earnings.
  • Percentage of Shares Shorted

    15.20% of the float of Mind Medicine (MindMed) has been sold short.
  • Short Interest Ratio / Days to Cover

    Mind Medicine (MindMed) has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

    Short interest in Mind Medicine (MindMed) has recently decreased by 6.03%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Mind Medicine (MindMed) does not currently pay a dividend.

  • Dividend Growth

    Mind Medicine (MindMed) does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.20% of the float of Mind Medicine (MindMed) has been sold short.
  • Short Interest Ratio / Days to Cover

    Mind Medicine (MindMed) has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

    Short interest in Mind Medicine (MindMed) has recently decreased by 6.03%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Mind Medicine (MindMed) has a news sentiment score of 1.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Mind Medicine (MindMed) this week, compared to 3 articles on an average week.
  • Search Interest

    16 people have searched for MNMD on MarketBeat in the last 30 days. This is an increase of 7% compared to the previous 30 days.
  • MarketBeat Follows

    17 people have added Mind Medicine (MindMed) to their MarketBeat watchlist in the last 30 days. This is an increase of 55% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Mind Medicine (MindMed) insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $311,644.00 in company stock.

  • Percentage Held by Insiders

    Only 2.45% of the stock of Mind Medicine (MindMed) is held by insiders.

  • Percentage Held by Institutions

    Only 27.91% of the stock of Mind Medicine (MindMed) is held by institutions.

  • Read more about Mind Medicine (MindMed)'s insider trading history.
Receive MNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE daily newsletter.

MNMD Stock News Headlines

MNMD Mind Medicine (MindMed) Inc. - Seeking Alpha
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
MindMed Announces New Employee Inducement Grants
See More Headlines

MNMD Stock Analysis - Frequently Asked Questions

Mind Medicine (MindMed)'s stock was trading at $6.96 at the start of the year. Since then, MNMD stock has increased by 3.4% and is now trading at $7.20.

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) posted its quarterly earnings results on Thursday, May, 8th. The company reported ($0.35) EPS for the quarter, topping analysts' consensus estimates of ($0.36) by $0.01.
Read the conference call transcript
.

Mind Medicine (MindMed) shares reverse split before market open on Monday, August 29th 2022.The 1-15 reverse split was announced on Monday, August 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of MNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mind Medicine (MindMed) investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Tesla (TSLA) and

Company Calendar

Last Earnings
5/08/2025
Today
7/06/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MNMD
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$25.50
High Stock Price Target
$55.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+254.2%
Consensus Rating
Buy
Rating Score (0-4)
3.27
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$108.68 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$3.21 per share
Price / Book
2.24

Miscellaneous

Free Float
73,702,000
Market Cap
$543.96 million
Optionable
Optionable
Beta
2.45
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:MNMD) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners